AstraZeneca Pharma India Ltd reports Q2 FY27 revenue of ₹7,291 million, up 30% year on year
- Revenue from operations rose from ₹5,591 million in Q2 FY26.
- The release also outlined regulatory approvals and healthcare collaborations and initiatives across several Indian states; operating margin and net profit were not disclosed.